Literature DB >> 18459146

Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.

Ya-Min Fu1, Zu-Xi Yu, Huimin Lin, Xing Fu, Gary G Meadows.   

Abstract

We previously found that selective restriction of amino acids inhibits invasion of two androgen-independent human prostate cancer cell lines, DU145 and PC3. Here we show that the restriction of tyrosine (Tyr) and phenylalanine (Phe), methionine (Met) or glutamine (Gln) modulates the activity of G proteins and affects the balance between two actin-binding proteins, cofilin and profilin, in these two cell lines. Selective amino acid restriction differentially reduces G protein binding to GTP in DU145 cells. Tyr/Phe deprivation reduces the amount of Rho-GTP and Rac1-GTP. Met deprivation reduces the amount of Ras-GTP and Rho-GTP, and Gln deprivation decreases Ras-GTP, Rac-GTP, and Cdc42-GTP. Restriction of these amino acids increases the amount of profilin, cofilin and phosphorylation of cofilin-Ser(3). Increased PAK1 expression and phosphorylation of PAK1-Thr(423), and Ser(199/204) are consistent with the increased phosphorylation of LIMK1-Thr(508). In PC3 cells, Tyr/Phe or Gln deprivation reduces the amount of Ras-GTP, and all of the examined amino acid restrictions reduce the amount of profilin. PAK1, LIMK1 and cofilin are not significantly altered. These data reveal that specific amino acid deprivation differentially affects actin dynamics in DU145 and PC3. Modulation on Rho, Rac, PAK1, and LIMK1 likely alter the balance between cofilin and profilin in DU145 cells. In contrast, profilin is inhibited in PC3 cells. These effects modulate directionality and motility to inhibit invasion. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459146      PMCID: PMC3401413          DOI: 10.1002/jcp.21490

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  53 in total

1.  Selective amino acid restriction targets mitochondria to induce apoptosis of androgen-independent prostate cancer cells.

Authors:  Ya-Min Fu; Hui Zhang; Mingjie Ding; Yi-Qi Li; Xing Fu; Zu-Xi Yu; Gary G Meadows
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

2.  Binding of activated alpha2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK.

Authors:  Uma Kant Misra; Rohit Deedwania; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2005-05-20       Impact factor: 5.157

3.  The cross talk between protein kinase A- and RhoA-mediated signaling in cancer cells.

Authors:  Yongchang Chen; Ying Wang; Hao Yu; Fengwei Wang; Wenrong Xu
Journal:  Exp Biol Med (Maywood)       Date:  2005-11

4.  Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling.

Authors:  Ya-Min Fu; Hui Zhang; Mingjie Ding; Yi-Qi Li; Xing Fu; Zu-Xi Yu; Gary G Meadows
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility.

Authors:  H Yao; E J Dashner; C M van Golen; K L van Golen
Journal:  Oncogene       Date:  2006-04-13       Impact factor: 9.867

6.  Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.

Authors:  R Zheng; A Iwase; R Shen; O B Goodman; N Sugimoto; Y Takuwa; D J Lerner; D M Nanus
Journal:  Oncogene       Date:  2006-05-01       Impact factor: 9.867

7.  Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions.

Authors:  Kwanchanit Tantivejkul; Ivana Vucenik; Abulkalam M Shamsuddin
Journal:  Anticancer Res       Date:  2003 Sep-Oct       Impact factor: 2.480

8.  FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase.

Authors:  Chun Zhou; Ming-Tat Ling; Terence Kin-Wah Lee; Kwan Man; Xianghong Wang; Yong-Chuan Wong
Journal:  Cancer Lett       Date:  2006-02-20       Impact factor: 8.679

9.  Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering.

Authors:  C M Wells; T Ahmed; J R W Masters; G E Jones
Journal:  Cell Motil Cytoskeleton       Date:  2005-11

Review 10.  Signaling to actin dynamics.

Authors:  L M Machesky; R H Insall
Journal:  J Cell Biol       Date:  1999-07-26       Impact factor: 10.539

View more
  9 in total

1.  Differential effects of specific amino acid restriction on glucose metabolism, reduction/oxidation status and mitochondrial damage in DU145 and PC3 prostate cancer cells.

Authors:  Xiaoyi Liu; Ya-Min Fu; Gary G Meadows
Journal:  Oncol Lett       Date:  2011-01-18       Impact factor: 2.967

2.  Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway.

Authors:  Lingqin Yuan; Xiugui Sheng; Adam K Willson; Dario R Roque; Jessica E Stine; Hui Guo; Hannah M Jones; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Endocr Relat Cancer       Date:  2015-06-04       Impact factor: 5.678

3.  Effect of Methionine Restriction on Bone Density and NK Cell Activity.

Authors:  Mingxin Li; Lidong Zhai; Wanfu Wei; Jingming Dong
Journal:  Biomed Res Int       Date:  2016-11-02       Impact factor: 3.411

4.  SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway.

Authors:  Yu-Jeong Choi; Youn Kyung Choi; Kang Min Lee; Sung-Gook Cho; Soo-Yeon Kang; Seong-Gyu Ko
Journal:  BMC Complement Altern Med       Date:  2016-12-07       Impact factor: 3.659

5.  Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4).

Authors:  Abhijeet Deshmukh; Frank Arfuso; Philip Newsholme; Arun Dharmarajan
Journal:  Cancers (Basel)       Date:  2018-01-31       Impact factor: 6.639

6.  A mixture of amino acids and other small molecules present in the serum suppresses the growth of murine and human tumors in vivo.

Authors:  Gyula Kulcsár; Dezső Gaál; Péter I Kulcsár; Ákos Schulcz; Tamás Czömpöly
Journal:  Int J Cancer       Date:  2012-08-24       Impact factor: 7.396

7.  TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer.

Authors:  Bingbing Wei; Jiabei Liang; Jimeng Hu; Yuanyuan Mi; Jun Ruan; Jian Zhang; Zhirong Wang; Qiang Hu; Haowen Jiang; Qiang Ding
Journal:  Med Sci Monit       Date:  2017-08-31

8.  JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.

Authors:  Juan Tan; Hao-Lian Wang; Jie Yang; Qian-Qian Liu; Chun-Min Li; Yun-Qian Wang; Lin-Na Fu; Qin-Yan Gao; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

9.  Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.

Authors:  Zhi-Feng Li; Yin-Di Yao; Yin-Yin Zhao; Yan Liu; Zhen-Hua Liu; Pei Hu; Zhuo-Ran Zhu
Journal:  J Clin Lab Anal       Date:  2020-05-28       Impact factor: 2.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.